Popular Articles

Achaogen Data Show Rapid Rise In Rates Of Resistance To Current Antibiotics
Achaogen, a clinical stage biopharmaceutical company addressing the issue of multi-drug resistant bacterial infections through the discovery and development of innovative broad-spectrum antibiotics, announced today the presentation of research on aminoglycoside (AG) resistance trends and comparative AG toxicities at the 19th Annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), being held May 16-19, 2009 in Helsinki, Finland.
generic viagra online
Gastrin Plays Significant Role In Helicobacter-Induced Stomach Cancer
A group led by Columbia University Medical Center"s Timothy Wang, M.D., has studied the role of Helicobacter infection in the development of stomach cancer and found that the hormone gastrin, which stimulates secretion of gastric acid, plays a key role in the development of Helicobacter-induced stomach cancer, and may have distinct effects on carcinogenesis in different parts of the stomach.
News of the day
Impax Receives FDA Approval For Generic Precose(R) Tablets, 25 Mg, 50 Mg And 100 Mg
Impax Laboratories, Inc. (NASDAQ: IPXL) confirmed that the U.S. Food and Drug Administration (FDA) has granted approval of the Company"s Abbreviated New Drug Application (ANDA) for generic versions of Precose® Tablets (acarbose), 25 mg, 50 mg and 100 mg strengths. Precose®, a Bayer HealthCare Pharmaceuticals product, is used in the management of type two diabetes mellitus.
Medical Devices

Patient-Centered Research Report Sent To Congress Outlining Research Priorities

Recommendations for how the HHS Office of the Secretary will spend $400 million in funds for patient-centered research, also known as comparative effectiveness research, were released by Federal Coordinating Council for Comparative Effectiveness Research (CER). The report, mandated by the American Recovery and Reinvestment Act, is designed to help the HHS Secretary and lawmakers improve the quality of care for patients, and provide patients and doctors the best information possible to make decisions about health care. The Federal Coordinating Council for Comparative Effectiveness Research report also catalogues current federal activities on CER, which had not been previously inventoried. The new report is available at http://www.hhs.gov/recovery/programs/cer. "This essential patient centered research will help give patients and doctors more information so they can make the best decisions," said HHS Secretary Kathleen Sebelius. "The council has produced an important tool that will help us better target our investments in this vital area of health care research. I was impressed by the amount of public input that was incorporated into their report; especially the focus on funding research for populations who have been left behind or left out." The council was charged by Congress with the task of identifying key areas of comparative effectiveness research where funding could make the greatest impact to improve health outcomes for our nation. The council heard many perspectives, including public input from hundreds of diverse stakeholders, which influenced the entire report. The report includes a definition of CER, criteria for determining which research projects should be a priority, and a strategic framework to identify gaps and future priorities. The council focused on the unique role that the Office of Secretary funds could play in complementing and leveraging funding currently allocated to the Agency for Healthcare Research and Quality, National Institutes of Health, and other government agencies. Recommendations include the following: - It is critically important to be able to share the results of comparative effectiveness research with doctors and patients and make better investments in how information is disseminated; - Research should focus on the needs of priority populations such as racial and ethnic minorities, persons with disabilities, persons with multiple chronic conditions, the elderly, and children; - Research should be in specific high-impact health arenas such as medical and assistive devices, surgical procedures, behavioral interventions and prevention; and - Investments should be made in data infrastructure such as linking current data s to enable answering CER questions, development of distributed electronic data networks and partnerships with the private sector. The council"s report will help to inform Secretary Sebelius" submission of an operational plan for the combined $1.1 billion allocated for patient-centered research, which includes the $400 million allocated to the Office of the Secretary at HHS. This investment will empower clinicians and patients with the information needed to achieve the best outcomes possible. HHS


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):